A7067558
Ceftizoximesodium , 10mMinDMSO , 68401-82-1
Synonym(s):
Ceftizoxime sodium
CAS NO.:68401-82-1
Empirical Formula: C13H14N5NaO5S2
Molecular Weight: 407.39
MDL number: MFCD01682036
EINECS: 629-729-8
| Pack Size | Price | Stock | Quantity |
| 1ml | RMB559.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 227℃ |
| RTECS | XI0368000 |
| storage temp. | -20°C |
| solubility | DMSO: soluble1mg/mL |
| form | solid |
| color | white to faint yellow |
| Water Solubility | Soluble in water |
| Stability: | Unstable in Solution |
| InChIKey | IYYQWKATOXYCHY-SFXQLROPNA-N |
| SMILES | O=C1[C@@H](NC(=O)/C(/C2N=C(N)SC=2)=N\OC)[C@@]2([H])SCC=C(C(=O)O)N12.[NaH] |&1:2,16,r| |
| CAS DataBase Reference | 68401-82-1(CAS DataBase Reference) |
Description and Uses
Ceftizoxime was synthesized by Fujisawa Pharmaceutical Industries in 1979. It possesses the (iminothiazolyl)methoxyiminomethyl group at the 7 position of the cephem nucleus, but there is no side chain at the 3 position. The compound shows excellent activity against gram-positive and gram-negative bacteria, behavior similar to that of cefotaxime. Unlike cefotaxime, however, it is not metabolized in vivo.
A broad spectrum antibiotic targeting a wide variety of Gram-positive and Gram-negative bacteria
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| WGK Germany | 3 |
| Toxicity | LD50 in mice, rats (mg/kg): ~6000 i.v. (Fukuhara) |




